Cytomegalovirus (CMV) infection is a common complication after liver transplantation, and it
is associated with multiple direct and indirect effects. Management of CMV infection and …

Background Up to 30% of cases of pouchitis are felt to have a secondary cause.
Cytomegalovirus (CMV) may represent a possible etiopathological agent. Here, we report …

Among solid organ transplant recipients, donor cytomegalovirus (CMV) seropositive (D+)
and recipient seronegative (R−) status are associated with an increased risk of graft loss and …

Purpose To evaluate epidemiology, risk‐factors, and outcomes of high‐level (HL)
cytomegalovirus (CMV) viremia in liver transplant recipients. Methods Adult patients …

Background Cytomegalovirus (CMV) disease is a significant complication after liver
transplantation. The estimated incidence varies among studies, which have been conducted …

Context.—Cytomegalovirus (CMV) hepatitis in allograft livers is an important infectious
complication, with histology that historically has been described to overlap with that of acute …

Introduction Advanced liver disease or cirrhosis is associated with an increased risk of
infections; however, the impact of high pretransplant model for end‐stage liver disease …

Background Despite advances in immunosuppressive therapy and post-transplantation
care, antiviral prevention, and therapy, cytomegalovirus (CMV) infection remains the most …

Background Cytomegalovirus (CMV) infection is one of the most common infectious
complications after solid organ transplant; it is associated with morbidity and mortality and …

Background The risk factors for development of viremia in high-risk donor cytomegalovirus
(CMV)-seropositive and recipient CMV-seronegative (D+ R−) transplant recipients are …